Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders

New scientific findings have recently shown that dasatinib (DAS), the first-choice oral drug in the treatment of chronic myeloid leukemia (CML) for adult patients who are resistant or intolerant to imatinib, is also potentially useful in the paediatric age. Moreover, recent preclinical evidences sug...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Cutrignelli, Annalisa, Sanarica, Francesca, Lopalco, Antonio, Lopedota, Angela, Laquintana, Valentino, Franco, Massimo, Boccanegra, Brigida, Mantuano, Paola, De Luca, Annamaria, Denora, Nunzio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386909/
https://ncbi.nlm.nih.gov/pubmed/30704045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20030591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados